Rare disorder potentially indicated for heart transplant

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:506225
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Orphanet code 506225 refers to a rare heart condition that may require a heart transplant as part of its treatment. This category covers serious disorders where the heart muscle becomes so damaged or weakened that it can no longer pump blood effectively to the rest of the body. These conditions are sometimes called end-stage heart disease or advanced cardiomyopathy. The heart may become enlarged, stiff, or structurally abnormal depending on the underlying cause. People with these conditions often experience symptoms like severe shortness of breath, extreme tiredness, fluid buildup in the legs or lungs, and an inability to do everyday activities. The heart's pumping function drops significantly, which means the body's organs do not get enough oxygen-rich blood. Over time, this can affect the kidneys, liver, and other vital organs. Treatment usually starts with medications to help the heart work better and reduce strain. Devices like pacemakers or defibrillators may also be used. When these options are no longer enough, a heart transplant may be considered. After transplant, patients need lifelong anti-rejection medications. The outlook varies widely depending on the specific underlying cause, how early it is caught, and how well the person responds to treatment.

Key symptoms:

Severe shortness of breath, especially during activity or when lying flatExtreme tiredness and low energySwelling in the legs, ankles, or feet due to fluid buildupRapid or irregular heartbeatDizziness or fainting spellsPersistent cough or wheezingReduced ability to exercise or do daily tasksBloating or swelling in the abdomenSudden weight gain from fluid retentionPale or bluish skin color

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Rare disorder potentially indicated for heart transplant.

View clinical trials →

No actively recruiting trials found for Rare disorder potentially indicated for heart transplant at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Rare disorder potentially indicated for heart transplant community →

No specialists are currently listed for Rare disorder potentially indicated for heart transplant.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Rare disorder potentially indicated for heart transplant.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Rare disorder potentially indicated for heart transplantForum →

No community posts yet. Be the first to share your experience with Rare disorder potentially indicated for heart transplant.

Start the conversation →

Latest news about Rare disorder potentially indicated for heart transplant

No recent news articles for Rare disorder potentially indicated for heart transplant.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.What is the specific diagnosis causing my heart condition, and is there a genetic cause?,Am I a candidate for a heart transplant, and what are the criteria?,What medications am I on, and what are the most important side effects to watch for?,Should my family members be tested for a possible inherited heart condition?,What warning signs should prompt me to go to the emergency room immediately?,Are there any clinical trials or new treatments I should know about?,What lifestyle changes, such as diet or activity restrictions, do I need to make right now?

Common questions about Rare disorder potentially indicated for heart transplant

What is Rare disorder potentially indicated for heart transplant?

Orphanet code 506225 refers to a rare heart condition that may require a heart transplant as part of its treatment. This category covers serious disorders where the heart muscle becomes so damaged or weakened that it can no longer pump blood effectively to the rest of the body. These conditions are sometimes called end-stage heart disease or advanced cardiomyopathy. The heart may become enlarged, stiff, or structurally abnormal depending on the underlying cause. People with these conditions often experience symptoms like severe shortness of breath, extreme tiredness, fluid buildup in the legs